ALC:NYSE
Alcon AG
67,83 US$
0,00%
(0,00) 1K
67,53 US$
arrow_downward
-0,44% (-0,30)todayBirjadan oldin
Savdolar yopilgan: 20-okt, 16:00:08 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Bozor kapitali
27,89 mlrd
Oʻrtacha hajm
1,77 mln
Hajmi
5,54 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,88
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Bozor kapitali
27,89 mlrd
Oʻrtacha hajm
1,77 mln
Hajmi
5,54 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,88
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com UK
·
16 soat oldin
Alcon acquires Neurotech for $550m to expand retina portfolio By Investing.com
Stock Traders Daily
·
17 soat oldin
Precision Trading with Alcon Inc. (ALC) Risk Zones
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25 ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
Sektor-
Veb-saytalcon.com